Maternal Antibodies Against Tetanus Toxoid Do Not Inhibit Potency of Antibody Responses to Autologous Antigen in Newborn Rhesus Monkeys

Overview

Journal J Med Primatol

Publisher Wiley

Date 2017 Jun 7

PMID 28585307

Citations 1

Authors

Ronald S Veazey

Yingjie Lu

Huanbin Xu

Widade Ziani

Lara A Doyle-Meyers

Marion S Ratterree

Xiaolei Wang

Affiliations

Soon will be listed here.

Abstract

Background: Our previous study suggested newborns have competent immune systems with the potential to respond to foreign antigens and vaccines. In this study, we examined infant immune responses to tetanus toxoid (TT) vaccination in the presence of maternal antibody to TT.

Methods: We examined changes in plasma levels of tetanus toxoid-specific IgG1 (anti-TT IgG1) in a total of eight infant rhesus macaques from birth through 6 months of age using a commercial Monkey Anti-TT IgG1 ELISA kit.

Results: A significant correlation between anti-TT IgG1 levels in vaccinated dams and their paired newborn infants was detected in control (non-vaccinated) infants as previously reported. Maternal anti-TT IgG1 levels declined rapidly within 1 month of birth in non-vaccinated infants (n=4). In four infants vaccinated with TT at birth, we found two had rapid and robust antibody responses to vaccination. Interestingly, the other two first showed declining TT antibody levels for 2 weeks followed by increasing levels without additional vaccine boosts, indicating all four had good antibody responses to primary TT vaccination at birth, despite the presence of high levels of maternal antibodies to TT in all four infants.

Conclusions: Our data indicate that newborn macaques have competent immune systems that are capable of generating their own primary antibody responses to vaccination, at least to tetanus antigens. Maternal antibodies thus do not significantly impair antibody response to the vaccination, even when received on the day of birth in infant rhesus macaques.

Citing Articles

Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models.

Ramos L, Lunney J, Gonzalez-Juarrero M Dis Model Mech. 2020; 13(9).

PMID: 32988990 PMC: 7520460. DOI: 10.1242/dmm.045740.

References

Glezen W . Effect of maternal antibodies on the infant immune response. Vaccine. 2003; 21(24):3389-92. DOI: 10.1016/s0264-410x(03)00339-6. View

Shen C, Xu H, Liu D, Veazey R, Wang X . Development of serum antibodies during early infancy in rhesus macaques: implications for humoral immune responses to vaccination at birth. Vaccine. 2014; 32(41):5337-5342. PMC: 4143459. DOI: 10.1016/j.vaccine.2014.07.036. View

Dengrove J, Lee E, Heiner D, ST GEME Jr J, Leake R, Baraff L . IgG and IgG subclass specific antibody responses to diphtheria and tetanus toxoids in newborns and infants given DTP immunization. Pediatr Res. 1986; 20(8):735-9. DOI: 10.1203/00006450-198608000-00007. View

Adkins B, Leclerc C, Marshall-Clarke S . Neonatal adaptive immunity comes of age. Nat Rev Immunol. 2004; 4(7):553-64. DOI: 10.1038/nri1394. View

Butler J, Lager K, Splichal I, Francis D, Kacskovics I, Sinkora M . The piglet as a model for B cell and immune system development. Vet Immunol Immunopathol. 2008; 128(1-3):147-70. PMC: 2828348. DOI: 10.1016/j.vetimm.2008.10.321. View

Siegrist C . Neonatal and early life vaccinology. Vaccine. 2001; 19(25-26):3331-46. DOI: 10.1016/s0264-410x(01)00028-7. View

Niewiesk S . Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol. 2014; 5:446. PMC: 4165321. DOI: 10.3389/fimmu.2014.00446. View

Kohler P, Farr R . Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature. 1966; 210(5040):1070-1. DOI: 10.1038/2101070a0. View

Jones C, Pollock L, Barnett S, Battersby A, Kampmann B . The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. Vaccine. 2013; 32(8):996-1002. DOI: 10.1016/j.vaccine.2013.11.104. View

10.

PrabhuDas M, Adkins B, Gans H, King C, Levy O, Ramilo O . Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol. 2011; 12(3):189-94. DOI: 10.1038/ni0311-189. View

11.

Morein B, Blomqvist G, Hu K . Immune responsiveness in the neonatal period. J Comp Pathol. 2007; 137 Suppl 1:S27-31. DOI: 10.1016/j.jcpa.2007.04.008. View

12.

Heiman H, Weisman L . Transplacental or enteral transfer of maternal immunization-induced antibody protects suckling rats from type III group B streptococcal infection. Pediatr Res. 1989; 26(6):629-32. DOI: 10.1203/00006450-198912000-00023. View

13.

Edwards K . Maternal antibodies and infant immune responses to vaccines. Vaccine. 2015; 33(47):6469-72. DOI: 10.1016/j.vaccine.2015.07.085. View

14.

Crowe Jr J . Influence of maternal antibodies on neonatal immunization against respiratory viruses. Clin Infect Dis. 2001; 33(10):1720-7. DOI: 10.1086/322971. View

15.

Palmeira P, Quinello C, Silveira-Lessa A, Zago C, Carneiro-Sampaio M . IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012; 2012:985646. PMC: 3251916. DOI: 10.1155/2012/985646. View

16.

Siegrist C, Aspinall R . B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009; 9(3):185-94. DOI: 10.1038/nri2508. View

17.

Chattha K, Firth M, Hodgins D, Shewen P . Expression of complement receptor 2 (CD21), membrane IgM and the inhibitory receptor CD32 (FcgammaRIIb) in the lymphoid tissues of neonatal calves. Vet Immunol Immunopathol. 2010; 137(1-2):99-108. DOI: 10.1016/j.vetimm.2010.04.016. View

18.

Svet-Moldavsky G, SVET-MOLDAVSKAYA I . SARCOMAS IN COTTON RATS INOCULATED WITH ROUS VIRUS. Science. 1964; 143(3601):54-5. DOI: 10.1126/science.143.3601.54. View

19.

Caceres V, Strebel P, Sutter R . Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis. 2000; 31(1):110-9. DOI: 10.1086/313926. View